6/19/2005
COPD
Quark Biotech Discovers Role of RTP801 as Signaling Molecule in Cigarette Smoking-Induced Pulmonary Injury...
4/28/2005
801 and Diabetes
Quark Biotech Discovers Role of RTP801 in the Pathogenesis of Early Diabetic Retinal Disease -Findings of Study To Be Presented at the 2005 ARVO Conference-
3/3/2005
US Patent on P53 Inhibitor
Quark Biotech Receives Notice of Allowance for U.S. Patent on p53 Inhibitor - Temporary suppression of p53 will allow protection of normal cells during stress inducing event such as chemotherapy
2/28/2005
Role of Ero-1L alpha Gene in Cancer
Quark Biotech Discovers Role of Ero-1L alpha Gene in Cancer: Involvement in Protein Secretion Under Hypoxic Conditions
2/8/2005
Sanwa and Quark
SANWA KAGAKU KENKYUSHO CO., LTD AND QUARK BIOTECH INC. ENTER COLLABORATION TO LICENSE DYSLIPIDEMIA THERAPY

 
Web Development HomeProductsContact ©2007 Quark Pharmaceuticals, Inc.